Catheter-linked UTIs more likely to resist antibiotics, large study finds
By
Alicia Lasek
Mar 28, 2023
The results emphasize the need for urine sampling and culturing before treating catheter-associated UTIs, and the importance of considering therapeutic alternatives, investigators say.
CDC: C. auris spreading at ‘alarming’ rate in U.S. healthcare facilities
By
Alicia Lasek
Mar 22, 2023
Drug-resistant Candida auris, a known threat to nursing homes, has spread rapidly, and a growing number of cases are resistant to first-line treatment, federal researchers report.
Post-op delirium tied to faster cognitive decline in 6-year study
By
Alicia Lasek
Mar 22, 2023
Postoperative delirium may speed the rate of cognitive decline in older adults by 40% within six years after a major elective surgery, a new study has found
Clinical briefs for Tuesday, March 21
By
Alicia Lasek
Mar 20, 2023
LeadingAge: MA program failures jeopardize health of nearly 30 million older adults … Behavioral health is crucial ingredient in new Michigan home care program … Patients prefer to see test results...
Initial symptoms of dementia predict speed of progression, study finds
By
Alicia Lasek
Mar 16, 2023
No matter the type of underlying brain changes, the first cognitive symptoms of dementia help predict long-term functional outcomes, researchers report.
Floor swabs an early warning sign of COVID-19 outbreaks, researchers say
By
Alicia Lasek
Mar 16, 2023
A 14-month program in 10 long-term care facilities has found that floor swabs accurately detect a COVID-19 outbreak days before it is identified by staff members.
CMS: Seniors to benefit as feds slash Medicare Part B co-insurances for 27 drugs
By
Alicia Lasek
Mar 16, 2023
A provision of the Inflation Reduction Act of 2022 will slash Medicare Part B co-insurances for 27 drugs between $2 and $390 per average dose beginning April 1. Certain vaccine cost-sharing will also be...
Medicare costs could soar with availability of new obesity drugs, experts say
By
Alicia Lasek
Mar 15, 2023
If efforts are successful to expand Medicare Part D to cover these drugs, premiums could soar, according to economists with Vanderbilt University and the University of Chicago.
FDA to withdraw certain drug-related guidances with end of PHE
By
Alicia Lasek
Mar 14, 2023
The Food and Drug Administration has issued a notice detailing which COVID-19-related guidances will expire when the public health emergency ends as scheduled on May 11, and which guidances will remain...
Health officials take aim at hepatitis with $11B plan, HBV screening update
By
Alicia Lasek
Mar 13, 2023
An $11 billion campaign has been proposed to eliminate hepatitis C infections. And the CDC has expanded its recommendations for hepatitis B screening to include all adults.